SAN DIEGO (AP) _ Sorrento Therapeutics Inc. (SRNE) on Tuesday reported a loss of $89.6 million in its third quarter.
The San Diego-based company said it had a loss of 20 cents per share.
The biopharmaceutical company posted revenue of $17.4 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SRNE at https://www.zacks.com/ap/SRNE
/A%20close-up%20of%20an%20AMD%20office%20by%20gehapromo%20via%20Adobe%20Stock.jpeg)
/A%20logo%20for%20Bending%20Spoons%20displayed%20on%20a%20smartphone%20screen%20by%20Timon%20via%20Adobe%20Stock.jpeg)
/ServiceNow%20Inc%20building%20in%20Silicon%20Valley-by%20Sundry%20Photography%20via%20iStock.jpg)
